Abbott Laboratories Common Stock [ABT]
The TickerPaging button is a members-only feature. (Million)
Annual Financial Data
Date | Revenue | NetIncome | Operating CF | Assets | Equity |
---|
2017/12 | 27,390 | 477 | 5,570 | 76,250 | 30,897 |
2018/12 | 30,578 | 2,368 | 6,300 | 67,173 | 30,524 |
2019/12 | 31,904 | 3,687 | 6,136 | 67,887 | 31,088 |
2020/12 | 34,608 | 4,495 | 7,901 | 72,548 | 32,784 |
2021/12 | 43,075 | 7,071 | 10,533 | 75,196 | 35,802 |
Annual Indicators
Date | Stock Price | BPS | PBR | EPS(Annual) | PER(Annual) |
---|
2017/12 | 57.07 | 17.76 | 3.21 | 0.27 | 211.37 |
2018/12 | 72.33 | 17.36 | 4.17 | 1.33 | 54.38 |
2019/12 | 86.86 | 17.58 | 4.94 | 2.06 | 42.17 |
2020/12 | 109.49 | 18.49 | 5.92 | 2.50 | 43.80 |
2021/12 | 140.74 | 20.17 | 6.98 | 3.94 | 35.72 |
Quarterly PL/CFS/BS
Date | Revenue | NetIncome | Operating CF | Operating CF Margin | Equity |
---|
2017/12 | 7,589 | -828 | 1,640 | 21.6% | 30,897 |
2018/03 | 7,390 | 418 | 1,108 | 15.0% | 31,399 |
2018/06 | 7,767 | 733 | 1,244 | 16.0% | 30,577 |
2018/09 | 7,656 | 563 | 2,183 | 28.5% | 30,705 |
2018/12 | 7,765 | 654 | 1,765 | 22.7% | 30,524 |
2019/03 | 7,535 | 672 | 712 | 9.4% | 30,925 |
2019/06 | 7,979 | 1,006 | 1,060 | 13.3% | 31,686 |
2019/09 | 8,076 | 960 | 1,948 | 24.1% | 31,817 |
2019/12 | 8,314 | 1,049 | 2,416 | 29.1% | 31,088 |
2020/03 | 7,726 | 564 | 715 | 9.3% | 30,218 |
2020/06 | 7,328 | 537 | 1,322 | 18.0% | 30,578 |
2020/09 | 8,853 | 1,232 | 2,066 | 23.3% | 31,386 |
2020/12 | 10,701 | 2,162 | 3,798 | 35.5% | 32,784 |
2021/03 | 10,456 | 1,793 | 2,637 | 25.2% | 33,562 |
2021/06 | 10,223 | 1,189 | 2,128 | 20.8% | 33,800 |
2021/09 | 10,928 | 2,100 | 2,701 | 24.7% | 34,422 |
2021/12 | 11,468 | 1,989 | 3,067 | 26.7% | 35,802 |
2022/03 | 11,895 | 2,447 | 2,065 | 17.4% | 35,399 |
2022/06 | 11,257 | 2,018 | 2,410 | 21.4% | 36,490 |
2022/09 | 10,410 | 1,435 | 2,780 | 26.7% | 35,675 |
Quarterly Indicators
Date | Stock Price | BPS | PBR | EPS(Quarterly) | PER(Annual conversion) | Outstanding Stocks |
---|
2017/12 | 57.07 | 17.76 | 3.21 | -0.48 | minus | 1,740 |
2018/03 | 59.92 | 17.91 | 3.35 | 0.23 | 65.13 | 1,753.412 |
2018/06 | 60.99 | 17.42 | 3.50 | 0.41 | 37.19 | 1,755.691 |
2018/09 | 73.36 | 17.48 | 4.20 | 0.32 | 57.31 | 1,757.018 |
2018/12 | 72.33 | 17.36 | 4.17 | 0.37 | 48.87 | 1,758 |
2019/03 | 79.94 | 17.54 | 4.56 | 0.38 | 52.59 | 1,763.278 |
2019/06 | 84.10 | 17.94 | 4.69 | 0.56 | 37.54 | 1,766.182 |
2019/09 | 83.67 | 18.00 | 4.65 | 0.53 | 39.47 | 1,767.985 |
2019/12 | 86.86 | 17.58 | 4.94 | 0.59 | 36.81 | 1,768 |
2020/03 | 78.91 | 17.08 | 4.62 | 0.31 | 63.64 | 1,768.901 |
2020/06 | 91.43 | 17.27 | 5.29 | 0.30 | 76.19 | 1,770.97 |
2020/09 | 108.83 | 17.71 | 6.15 | 0.69 | 39.43 | 1,772.166 |
2020/12 | 109.49 | 18.49 | 5.92 | 1.20 | 22.81 | 1,773 |
2021/03 | 119.84 | 18.89 | 6.34 | 1.00 | 29.96 | 1,776.842 |
2021/06 | 115.93 | 19.01 | 6.10 | 0.66 | 43.91 | 1,778.049 |
2021/09 | 118.13 | 19.37 | 6.10 | 1.17 | 25.24 | 1,776.87 |
2021/12 | 140.74 | 20.17 | 6.98 | 1.11 | 31.70 | 1,775 |
2022/03 | 118.36 | 20.09 | 5.89 | 1.37 | 21.60 | 1,761.911 |
2022/06 | 108.65 | 20.76 | 5.23 | 1.14 | 23.83 | 1,757.858 |
2022/09 | 96.76 | 20.31 | 4.76 | 0.81 | 29.86 | 1,756.209 |
About The Unit
- Revenue,NetIncome,Operating CashFlow,Assets,StockHolder's Equity : Million Dollars
- StockPrice,BPS,EPS,DPS : One USD
- Outstanding Stocks : Million Stocks
- PPBR,PER: Integer multiple